These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15668004)

  • 1. The effect of passaging in liquid media and storage on Mycobacterium bovis--BCG growth capacity and infectivity.
    Nascimento IP; Leite LC
    FEMS Microbiol Lett; 2005 Feb; 243(1):81-6. PubMed ID: 15668004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
    Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
    Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guerin in human macrophages and in mice.
    Bottai D; Esin S; Batoni G; Pardini M; Maisetta G; Donati V; Favilli F; Florio W; Campa M
    Res Microbiol; 2005 Apr; 156(3):393-402. PubMed ID: 15808944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4.
    Qie YQ; Wang JL; Liu W; Shen H; Chen JZ; Zhu BD; Xu Y; Zhang XL; Wang HH
    Scand J Immunol; 2009 Apr; 69(4):342-50. PubMed ID: 19284499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Mycobacterium bovis BCG.
    Bastos RG; Borsuk S; Seixas FK; Dellagostin OA
    Vaccine; 2009 Nov; 27(47):6495-503. PubMed ID: 19720367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an in vitro model using NR8383 cells and Mycobacterium bovis Calmette-Guerin that mimics a chronic infection of Mycobacterium tuberculosis.
    Hino M; Oda M; Yoshida A; Nakata K; Kohchi C; Nishizawa T; Inagawa H; Hori H; Makino K; Terada H; Soma G
    In Vivo; 2005; 19(5):821-30. PubMed ID: 16097433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
    Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
    J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis.
    Wedlock DN; Denis M; Vordermeier HM; Hewinson RG; Buddle BM
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):50-8. PubMed ID: 17524495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
    Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
    J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BCG: substrains, the vaccine, vaccination].
    Balazs ED
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(3):117-24. PubMed ID: 9417279
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guérin (BCG) substrains.
    Hayashi D; Takii T; Fujiwara N; Fujita Y; Yano I; Yamamoto S; Kondo M; Yasuda E; Inagaki E; Kanai K; Fujiwara A; Kawarazaki A; Chiba T; Onozaki K
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):116-28. PubMed ID: 19453755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
    Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
    Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of passages during Japanese BCG vaccine production on genetic stability and protective efficacy.
    Seki M; Udagawa T; Sugawara I; Iwama K; Honda I; Fujita I; Hashimoto A; Yano I; Yamamoto S
    Vaccine; 2012 Feb; 30(8):1460-4. PubMed ID: 22226863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines.
    Florio W; Brancatisano FL; Bottai D; Esin S; Di Luca M; Counoupas C; Maisetta G; Lupetti A; Batoni G; Campa M
    Can J Microbiol; 2009 Aug; 55(8):975-82. PubMed ID: 19898537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research.
    Chege GK; Williamson AL; Passmore JS; Bourn W; Ryffel B; Shephard EG
    Vaccine; 2005 Dec; 23(50):5783-91. PubMed ID: 16214269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge.
    Wang Q; Li J; Zhang X; Liu Q; Liu C; Ma G; Cao L; Gong P; Cai Y; Zhang G
    Vet Parasitol; 2009 Mar; 160(3-4):198-203. PubMed ID: 19117681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.